معرفی
Harry Iland is Clinical Professor in the Sydney Medical School at the University of Sydney, specializing in hematological malignancies. His research focuses on acute promyelocytic leukemia (APL) and molecular diagnostics.
He leads clinical trials through the Australasian Leukaemia and Lymphoma Group and investigates molecular abnormalities in blood cancers. Contributions include developing arsenic trioxide treatment protocols for APL.
۰مقاله منتشرشده
